MarketCap
Facebook
X
Telegram
Checkmate Pharmaceuticals Current Ratio | CMPI
Annual Current Ratio Checkmate Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 8.41 | 16.9 | 0.91 | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.9 | 0.91 | 8.74 |
Quarterly Current Ratio Checkmate Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 5.61 | 8.41 | 11.4 | 15.2 | 16.4 | 16.9 | 16.3 | 11.9 | 16.9 | 0.91 | 0.91 | 0.91 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 16.9 | 0.91 | 10.1 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Gossamer Bio
GOSS
|
0.584 | $ 11.2 | 5.21 % | $ 2.56 B |  USA |
 |
GeoVax Labs
GOVX
|
2.52 | $ 0.11 | -22.17 % | $ 105 K | USA |
 |
United Therapeutics Corporation
UTHR
|
10.1 | $ 588.33 | 1.01 % | $ 26.1 B | USA |
 |
Seelos Therapeutics
SEEL
|
0.139 | - | -47.76 % | $ 6.27 M | USA |
 |
Vericel Corporation
VCEL
|
3.66 | $ 59.02 | 1.08 % | $ 2.97 B | USA |
 |
Veracyte
VCYT
|
14.6 | $ 24.05 | -7.21 % | $ 1.89 B | USA |
 |
Advaxis
ADXS
|
3.37 | - | -9.65 % | $ 45.9 M | USA |
 |
GlaxoSmithKline plc
GSK
|
1.35 | $ 51.25 | -0.56 % | $ 208 B |  Britain |
 |
Vir Biotechnology
VIR
|
4.22 | $ 13.17 | -3.48 % | $ 1.82 B | USA |
 |
Viking Therapeutics
VKTX
|
9.34 | $ 28.67 | -1.1 % | $ 3.23 B | USA |
 |
Vanda Pharmaceuticals
VNDA
|
3.02 | $ 4.07 | -0.49 % | $ 240 M | USA |
 |
Verrica Pharmaceuticals
VRCA
|
2.11 | $ 3.55 | -1.11 % | $ 37.8 M | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
3.68 | $ 547.74 | -0.57 % | $ 140 B | USA |
 |
Kiromic BioPharma
KRBP
|
0.404 | - | 6.61 % | $ 3.08 M | USA |
 |
vTv Therapeutics
VTVT
|
3.53 | $ 20.88 | -1.42 % | $ 83.8 M | USA |
 |
CNS Pharmaceuticals
CNSP
|
2.1 | $ 3.81 | -3.3 % | $ 1.69 M | USA |
 |
Voyager Therapeutics
VYGR
|
4.49 | $ 1.82 | -8.54 % | $ 107 M | USA |
 |
Calithera Biosciences
CALA
|
3.46 | - | -10.95 % | $ 876 K | USA |
 |
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | USA |
 |
Wave Life Sciences Ltd.
WVE
|
5.69 | $ 3.41 | -2.01 % | $ 575 M |  Singapore |
 |
Molecular Templates
MTEM
|
1.14 | - | -23.43 % | $ 495 K | USA |
 |
Exicure
XCUR
|
1.39 | $ 1.08 | 21.31 % | $ 6.8 M | USA |
 |
Immunome
IMNM
|
14 | $ 18.65 | -3.67 % | $ 1.63 B | USA |
 |
Xeris Pharmaceuticals
XERS
|
1.04 | $ 15.81 | -0.35 % | $ 2.54 B | USA |
 |
X4 Pharmaceuticals
XFOR
|
2.79 | $ 3.24 | -2.7 % | $ 137 M | USA |
 |
Xencor
XNCR
|
3.65 | $ 39.42 | 2.16 % | $ 2.93 B | USA |
 |
INmune Bio
INMB
|
3.67 | $ 1.09 | -3.54 % | $ 27 M | USA |
 |
Insmed Incorporated
INSM
|
1.48 | $ 119.55 | 2.97 % | $ 23.8 B | USA |
 |
Ionis Pharmaceuticals
IONS
|
1.16 | $ 28.02 | -9.63 % | $ 4.48 B | USA |
 |
BioXcel Therapeutics
BTAI
|
0.32 | $ 0.07 | 9.81 % | $ 855 K | USA |
 |
InflaRx N.V.
IFRX
|
4.04 | $ 1.21 | -7.63 % | $ 81.4 M |  Germany |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
1.46 | $ 1.78 | 16.33 % | $ 1.2 B |  Israel |
 |
22nd Century Group
XXII
|
3.17 | $ 1.46 | -10.43 % | $ 269 K | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
7.5 | $ 4.82 | 2.99 % | $ 780 M | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
4.47 | $ 245.39 | 0.76 % | $ 15 B |  Irlanda |
 |
Zai Lab Limited
ZLAB
|
2.57 | $ 26.56 | -1.12 % | $ 29.1 B |  China |
 |
Zentalis Pharmaceuticals
ZNTL
|
3.97 | $ 1.8 | 3.16 % | $ 129 M | USA |
 |
CohBar
CWBR
|
15.8 | - | -15.44 % | $ 2.2 M | USA |
 |
Zoetis
ZTS
|
1.27 | $ 82.45 | 0.15 % | $ 36.6 B | USA |
 |
NeuBase Therapeutics
NBSE
|
3.48 | - | -1.56 % | $ 12.3 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
3.86 | - | - | $ 2.18 B | USA |
 |
Arena Pharmaceuticals
ARNA
|
10.8 | - | -6.81 % | $ 3.04 B | USA |
 |
Scopus BioPharma
SCPS
|
0.519 | - | -48.37 % | $ 3.71 M | USA |
 |
Annovis Bio
ANVS
|
4.98 | $ 0.85 | -5.53 % | $ 17.5 M | USA |
 |
scPharmaceuticals
SCPH
|
1.14 | - | - | $ 218 M | USA |
 |
Johnson & Johnson
JNJ
|
1.69 | $ 281.13 | -0.35 % | $ 677 B | USA |
 |
Kala Pharmaceuticals
KALA
|
3.81 | $ 0.17 | -2.59 % | $ 1.39 M | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
4.22 | - | - | $ 105 M | USA |
 |
Athersys
ATHX
|
2.11 | - | 3.77 % | $ 22.4 M | USA |
 |
Global Blood Therapeutics
GBT
|
1.26 | - | - | $ 4.62 B | USA |